Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential steroidal antiestrogens

E R Clark, A M Omar, G Prestwich

    Journal of Medicinal Chemistry
    |August 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Researchers synthesized novel 17beta-estradiol analogues and tested their estrogen receptor binding and antiuterotrophic activity. Compound 14 showed the highest binding affinity, while compound 15 exhibited significant uterine weight increase in rats, indicating potential selective estrogenic effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study.

    QJM : monthly journal of the Association of Physicians·2021
    Same author

    Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents.

    MedChemComm·2020
    Same author

    Fungal deterioration of limestone false-door monument.

    Heliyon·2019
    Same author

    Enhancing electron affinity and tuning band gap in donor-acceptor organic semiconductors by benzothiadiazole directed C-H borylation.

    Chemical science·2017
    Same author

    Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents.

    Organic & biomolecular chemistry·2015
    Same author

    Arterial anastomoses.

    The Biological bulletin·2010
    Same journal

    Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

    Journal of medicinal chemistry·2026
    Same journal

    3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

    Journal of medicinal chemistry·2026
    Same journal

    A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

    Journal of medicinal chemistry·2026
    Same journal

    A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

    Journal of medicinal chemistry·2026
    See all related articles

    Area of Science:

    • Medicinal Chemistry
    • Endocrinology
    • Pharmacology

    Background:

    • 17beta-estradiol is a key hormone regulating reproductive functions.
    • Developing selective estrogen receptor modulators (SERMs) is crucial for therapeutic applications.
    • Structure-activity relationships of estradiol analogues inform drug design.

    Purpose of the Study:

    • To synthesize and evaluate novel 17beta-estradiol analogues for estrogen receptor binding.
    • To assess the antiuterotrophic activity of synthesized compounds in vivo.
    • To identify potent and selective estrogen receptor modulators.

    Main Methods:

    • Synthesis of 17beta-estradiol analogues.
    • Sucrose density gradient analysis for estrogen receptor binding assays.

    Related Experiment Videos

  • In vivo antiuterotrophic activity testing in immature rats and mice.

    • Main Results:

    • Compound 14 (3,17beta-dihydroxy-6-phenylestra-1,3,5(10),6-tetraene) demonstrated potent inhibition of [6,7-3H]-17beta-estradiol binding.
    • Structural modifications, such as 1-methyl substitution or conversion of 3-OH, significantly affected receptor affinity.
    • Compound 15 induced a significant increase in uterine weight in immature rats, but not in mice, at high molar ratios.

    Conclusions:

    • Novel 17beta-estradiol analogues were successfully synthesized and characterized.
    • Compound 14 exhibits high affinity for the estrogen receptor.
    • Compound 15 displays selective in vivo estrogenic activity in rats, suggesting potential for targeted therapeutic development.